Approval · Notice of Compliance 32877 · 2024
ACUVAIL: Notice of Compliance 32877
Issued March 14, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 32877
- Date
- March 14, 2024
- Company
- AbbVie CorporationSaint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of two new leachable impurities to the drug product specification and analytical procedure.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ACUVAIL | Not yet assigned | — |
Medicinal ingredients
- KETOROLAC TROMETHAMINE 0.45 PER